SCHEMBL8993326

SCHEMBL8993326

CCOC(=O)c1ccc(Cc2ccc(C)cc2)c(OC)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 1/20 0.59
SMN1; SMN2 Q16637 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
KDM4E B2RXH2 2/20 0.47
POLB P06746 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47
LMNA P02545 4/20 0.46
HPGD P15428 2/20 0.46
MAPT P10636 5/20 0.46
CTNNB1 P35222 1/20 0.46
WNT3A P56704 1/20 0.46
TSHR P16473 1/20 0.46
GAA P10253 3/20 0.46
KMT2A Q03164 4/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8992999 0.91 HSD17B2 (0.58) HSD17B2SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL4281415 0.83 CA12 (0.60) HSD17B2SMN1; SMN2NPC1RAB9APOLB
SCHEMBL8993227 0.83 HSD17B2 (0.58) HSD17B2SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL8992779 0.82 HSD17B2 (0.61) HSD17B2SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL14582858 0.81 HSD17B2 (0.68) HSD17B2SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL5161173 0.80 HSD17B2 (0.66) HSD17B2SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL14366059 0.79 ALDH1A1 (0.54) SMN1; SMN2RAB9ACA12CA1CA2
SCHEMBL3904758 0.78 HSD17B2 (0.62) HSD17B2SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL30506315 0.78 HSD17B2 (0.76) HSD17B2SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL1660365 0.78 HSD17B2 (0.76) HSD17B2SMN1; SMN2NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5516777-A PROSTATE CANCER THERAPY OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1996-05-14 US disclosed
US-5409928-A Prostate diseases, alopecia OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-04-25 US disclosed
EP-0594149-A2 Condensed pyrazole derivatives, method of manufacturing the same, and androgen inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-04-27 EP disclosed